Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993848347> ?p ?o ?g. }
- W1993848347 endingPage "1583" @default.
- W1993848347 startingPage "1581" @default.
- W1993848347 abstract "Antiretroviral (ARV) treatment decisions are difficult for HIV-1-infected patients on complex treatment regimens who have partial suppression of HIV-1 replication and limited treatment options. Information on the ARV activity of the components of a complex regimen would be useful. Sixteen subjects who had received prolonged therapy with zidovudine (ZDV) and lamivudine (3TC), with a median duration of 32.5 months, were discontinuing this dual-nucleoside regimen and volunteered to have plasma HIV-1 RNA levels monitored over the 2 weeks after discontinuation. All subjects experienced an increase in HIV-1 RNA after discontinuation, with a median increase of 0.54 log10 copies/mL over 2 weeks (range: 0.31-1.71; P < 0.001). An inverse correlation existed between the decline in HIV-1 RNA levels over 2 to 3 years on nucleoside analogue therapy and the increase over the 10 to 14 days off therapy (Spearman r = −0.53; P = 0.036). Over the 2-week period, a subset of individuals who had genotype testing at multiple reverse transcriptase codons associated with ZDV and 3TC resistance had no changes in genotype off therapy. Nucleoside analogue reverse transcriptase inhibitors may have continued ARV activity despite long durations of partially suppressive therapy and the presence of resistant HIV-1." @default.
- W1993848347 created "2016-06-24" @default.
- W1993848347 creator A5004267463 @default.
- W1993848347 creator A5016314806 @default.
- W1993848347 creator A5021176687 @default.
- W1993848347 creator A5024560316 @default.
- W1993848347 creator A5054645317 @default.
- W1993848347 creator A5058715015 @default.
- W1993848347 creator A5072376702 @default.
- W1993848347 creator A5079878752 @default.
- W1993848347 creator A5087616048 @default.
- W1993848347 date "2004-12-01" @default.
- W1993848347 modified "2023-10-16" @default.
- W1993848347 title "Persistent Antiretroviral Activity of Nucleoside Analogues After Prolonged Zidovudine and Lamivudine Therapy as Demonstrated by Rapid Loss of Activity After Discontinuation" @default.
- W1993848347 cites W1692566697 @default.
- W1993848347 cites W1965317332 @default.
- W1993848347 cites W1998085351 @default.
- W1993848347 cites W2021037491 @default.
- W1993848347 cites W2058829670 @default.
- W1993848347 cites W2069820433 @default.
- W1993848347 cites W2080198736 @default.
- W1993848347 cites W2102133068 @default.
- W1993848347 cites W2155449170 @default.
- W1993848347 cites W2331453856 @default.
- W1993848347 cites W2331670444 @default.
- W1993848347 doi "https://doi.org/10.1097/00126334-200412150-00009" @default.
- W1993848347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15577413" @default.
- W1993848347 hasPublicationYear "2004" @default.
- W1993848347 type Work @default.
- W1993848347 sameAs 1993848347 @default.
- W1993848347 citedByCount "34" @default.
- W1993848347 countsByYear W19938483472012 @default.
- W1993848347 countsByYear W19938483472013 @default.
- W1993848347 countsByYear W19938483472016 @default.
- W1993848347 countsByYear W19938483472020 @default.
- W1993848347 crossrefType "journal-article" @default.
- W1993848347 hasAuthorship W1993848347A5004267463 @default.
- W1993848347 hasAuthorship W1993848347A5016314806 @default.
- W1993848347 hasAuthorship W1993848347A5021176687 @default.
- W1993848347 hasAuthorship W1993848347A5024560316 @default.
- W1993848347 hasAuthorship W1993848347A5054645317 @default.
- W1993848347 hasAuthorship W1993848347A5058715015 @default.
- W1993848347 hasAuthorship W1993848347A5072376702 @default.
- W1993848347 hasAuthorship W1993848347A5079878752 @default.
- W1993848347 hasAuthorship W1993848347A5087616048 @default.
- W1993848347 hasConcept C104317684 @default.
- W1993848347 hasConcept C126322002 @default.
- W1993848347 hasConcept C142462285 @default.
- W1993848347 hasConcept C156719811 @default.
- W1993848347 hasConcept C159047783 @default.
- W1993848347 hasConcept C2522874641 @default.
- W1993848347 hasConcept C2776543447 @default.
- W1993848347 hasConcept C2776999253 @default.
- W1993848347 hasConcept C2777333352 @default.
- W1993848347 hasConcept C2777351918 @default.
- W1993848347 hasConcept C2777869810 @default.
- W1993848347 hasConcept C2778715236 @default.
- W1993848347 hasConcept C2779889181 @default.
- W1993848347 hasConcept C2780216070 @default.
- W1993848347 hasConcept C2780593183 @default.
- W1993848347 hasConcept C2780727368 @default.
- W1993848347 hasConcept C2781413609 @default.
- W1993848347 hasConcept C2909970146 @default.
- W1993848347 hasConcept C2993143319 @default.
- W1993848347 hasConcept C3013748606 @default.
- W1993848347 hasConcept C55493867 @default.
- W1993848347 hasConcept C67705224 @default.
- W1993848347 hasConcept C71924100 @default.
- W1993848347 hasConcept C86803240 @default.
- W1993848347 hasConcept C90924648 @default.
- W1993848347 hasConcept C98274493 @default.
- W1993848347 hasConceptScore W1993848347C104317684 @default.
- W1993848347 hasConceptScore W1993848347C126322002 @default.
- W1993848347 hasConceptScore W1993848347C142462285 @default.
- W1993848347 hasConceptScore W1993848347C156719811 @default.
- W1993848347 hasConceptScore W1993848347C159047783 @default.
- W1993848347 hasConceptScore W1993848347C2522874641 @default.
- W1993848347 hasConceptScore W1993848347C2776543447 @default.
- W1993848347 hasConceptScore W1993848347C2776999253 @default.
- W1993848347 hasConceptScore W1993848347C2777333352 @default.
- W1993848347 hasConceptScore W1993848347C2777351918 @default.
- W1993848347 hasConceptScore W1993848347C2777869810 @default.
- W1993848347 hasConceptScore W1993848347C2778715236 @default.
- W1993848347 hasConceptScore W1993848347C2779889181 @default.
- W1993848347 hasConceptScore W1993848347C2780216070 @default.
- W1993848347 hasConceptScore W1993848347C2780593183 @default.
- W1993848347 hasConceptScore W1993848347C2780727368 @default.
- W1993848347 hasConceptScore W1993848347C2781413609 @default.
- W1993848347 hasConceptScore W1993848347C2909970146 @default.
- W1993848347 hasConceptScore W1993848347C2993143319 @default.
- W1993848347 hasConceptScore W1993848347C3013748606 @default.
- W1993848347 hasConceptScore W1993848347C55493867 @default.
- W1993848347 hasConceptScore W1993848347C67705224 @default.
- W1993848347 hasConceptScore W1993848347C71924100 @default.
- W1993848347 hasConceptScore W1993848347C86803240 @default.
- W1993848347 hasConceptScore W1993848347C90924648 @default.
- W1993848347 hasConceptScore W1993848347C98274493 @default.
- W1993848347 hasIssue "5" @default.